nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—CYP1A2—Progesterone—uterine cancer	0.189	0.691	CbGbCtD
Anagrelide—CYP1A2—Etoposide—uterine cancer	0.0846	0.309	CbGbCtD
Anagrelide—Convulsion—Etoposide—uterine cancer	0.000791	0.00109	CcSEcCtD
Anagrelide—Dehydration—Epirubicin—uterine cancer	0.00079	0.00109	CcSEcCtD
Anagrelide—Hypertension—Etoposide—uterine cancer	0.000788	0.00109	CcSEcCtD
Anagrelide—Osteoarthritis—Doxorubicin—uterine cancer	0.000786	0.00108	CcSEcCtD
Anagrelide—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000786	0.00108	CcSEcCtD
Anagrelide—Diplopia—Doxorubicin—uterine cancer	0.000786	0.00108	CcSEcCtD
Anagrelide—Liver function test abnormal—Epirubicin—uterine cancer	0.000784	0.00108	CcSEcCtD
Anagrelide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000784	0.00108	CcSEcCtD
Anagrelide—Dry skin—Epirubicin—uterine cancer	0.000779	0.00107	CcSEcCtD
Anagrelide—Chest pain—Etoposide—uterine cancer	0.000777	0.00107	CcSEcCtD
Anagrelide—Orthostatic hypotension—Epirubicin—uterine cancer	0.000776	0.00107	CcSEcCtD
Anagrelide—Migraine—Doxorubicin—uterine cancer	0.000774	0.00107	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000772	0.00106	CcSEcCtD
Anagrelide—Discomfort—Etoposide—uterine cancer	0.000768	0.00106	CcSEcCtD
Anagrelide—Gastritis—Epirubicin—uterine cancer	0.000752	0.00104	CcSEcCtD
Anagrelide—Confusional state—Etoposide—uterine cancer	0.000751	0.00103	CcSEcCtD
Anagrelide—Infection—Etoposide—uterine cancer	0.00074	0.00102	CcSEcCtD
Anagrelide—Asthenia—Dactinomycin—uterine cancer	0.000738	0.00102	CcSEcCtD
Anagrelide—Blood creatinine increased—Doxorubicin—uterine cancer	0.000736	0.00101	CcSEcCtD
Anagrelide—Influenza—Epirubicin—uterine cancer	0.000734	0.00101	CcSEcCtD
Anagrelide—Asthma—Epirubicin—uterine cancer	0.000734	0.00101	CcSEcCtD
Anagrelide—Dysphagia—Epirubicin—uterine cancer	0.000734	0.00101	CcSEcCtD
Anagrelide—Dehydration—Doxorubicin—uterine cancer	0.000731	0.00101	CcSEcCtD
Anagrelide—Thrombocytopenia—Etoposide—uterine cancer	0.000729	0.001	CcSEcCtD
Anagrelide—Tachycardia—Etoposide—uterine cancer	0.000727	0.001	CcSEcCtD
Anagrelide—Liver function test abnormal—Doxorubicin—uterine cancer	0.000726	0.000999	CcSEcCtD
Anagrelide—Skin disorder—Etoposide—uterine cancer	0.000724	0.000996	CcSEcCtD
Anagrelide—Dry skin—Doxorubicin—uterine cancer	0.000721	0.000992	CcSEcCtD
Anagrelide—Hyperhidrosis—Etoposide—uterine cancer	0.00072	0.000992	CcSEcCtD
Anagrelide—Pancreatitis—Epirubicin—uterine cancer	0.00072	0.000991	CcSEcCtD
Anagrelide—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000718	0.000989	CcSEcCtD
Anagrelide—Angina pectoris—Epirubicin—uterine cancer	0.000715	0.000985	CcSEcCtD
Anagrelide—Anorexia—Etoposide—uterine cancer	0.00071	0.000978	CcSEcCtD
Anagrelide—Bronchitis—Epirubicin—uterine cancer	0.000706	0.000972	CcSEcCtD
Anagrelide—Diarrhoea—Dactinomycin—uterine cancer	0.000704	0.00097	CcSEcCtD
Anagrelide—Pancytopenia—Epirubicin—uterine cancer	0.000697	0.00096	CcSEcCtD
Anagrelide—Hypotension—Etoposide—uterine cancer	0.000696	0.000958	CcSEcCtD
Anagrelide—Gastritis—Doxorubicin—uterine cancer	0.000696	0.000958	CcSEcCtD
Anagrelide—Dysuria—Epirubicin—uterine cancer	0.000687	0.000945	CcSEcCtD
Anagrelide—Dysphagia—Doxorubicin—uterine cancer	0.000679	0.000936	CcSEcCtD
Anagrelide—Asthma—Doxorubicin—uterine cancer	0.000679	0.000936	CcSEcCtD
Anagrelide—Influenza—Doxorubicin—uterine cancer	0.000679	0.000936	CcSEcCtD
Anagrelide—Pollakiuria—Epirubicin—uterine cancer	0.000678	0.000934	CcSEcCtD
Anagrelide—Photosensitivity reaction—Epirubicin—uterine cancer	0.00067	0.000923	CcSEcCtD
Anagrelide—Paraesthesia—Etoposide—uterine cancer	0.000669	0.000921	CcSEcCtD
Anagrelide—Weight increased—Epirubicin—uterine cancer	0.000668	0.00092	CcSEcCtD
Anagrelide—Pancreatitis—Doxorubicin—uterine cancer	0.000666	0.000917	CcSEcCtD
Anagrelide—Weight decreased—Epirubicin—uterine cancer	0.000664	0.000915	CcSEcCtD
Anagrelide—Dyspnoea—Etoposide—uterine cancer	0.000664	0.000914	CcSEcCtD
Anagrelide—Somnolence—Etoposide—uterine cancer	0.000662	0.000912	CcSEcCtD
Anagrelide—Angina pectoris—Doxorubicin—uterine cancer	0.000662	0.000911	CcSEcCtD
Anagrelide—Pneumonia—Epirubicin—uterine cancer	0.000659	0.000907	CcSEcCtD
Anagrelide—Vomiting—Dactinomycin—uterine cancer	0.000654	0.000901	CcSEcCtD
Anagrelide—Bronchitis—Doxorubicin—uterine cancer	0.000653	0.0009	CcSEcCtD
Anagrelide—Rash—Dactinomycin—uterine cancer	0.000649	0.000894	CcSEcCtD
Anagrelide—Decreased appetite—Etoposide—uterine cancer	0.000648	0.000892	CcSEcCtD
Anagrelide—Pancytopenia—Doxorubicin—uterine cancer	0.000645	0.000888	CcSEcCtD
Anagrelide—Renal failure—Epirubicin—uterine cancer	0.000644	0.000886	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Etoposide—uterine cancer	0.000643	0.000886	CcSEcCtD
Anagrelide—Fatigue—Etoposide—uterine cancer	0.000642	0.000884	CcSEcCtD
Anagrelide—Pain—Etoposide—uterine cancer	0.000637	0.000877	CcSEcCtD
Anagrelide—Constipation—Etoposide—uterine cancer	0.000637	0.000877	CcSEcCtD
Anagrelide—Urinary tract infection—Epirubicin—uterine cancer	0.000636	0.000876	CcSEcCtD
Anagrelide—Conjunctivitis—Epirubicin—uterine cancer	0.000636	0.000876	CcSEcCtD
Anagrelide—Dysuria—Doxorubicin—uterine cancer	0.000635	0.000875	CcSEcCtD
Anagrelide—Sweating—Epirubicin—uterine cancer	0.000628	0.000864	CcSEcCtD
Anagrelide—Pollakiuria—Doxorubicin—uterine cancer	0.000628	0.000864	CcSEcCtD
Anagrelide—Haematuria—Epirubicin—uterine cancer	0.000624	0.00086	CcSEcCtD
Anagrelide—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00062	0.000854	CcSEcCtD
Anagrelide—Hepatobiliary disease—Epirubicin—uterine cancer	0.000619	0.000853	CcSEcCtD
Anagrelide—Weight increased—Doxorubicin—uterine cancer	0.000618	0.000851	CcSEcCtD
Anagrelide—Epistaxis—Epirubicin—uterine cancer	0.000618	0.00085	CcSEcCtD
Anagrelide—Weight decreased—Doxorubicin—uterine cancer	0.000615	0.000846	CcSEcCtD
Anagrelide—Sinusitis—Epirubicin—uterine cancer	0.000614	0.000846	CcSEcCtD
Anagrelide—Feeling abnormal—Etoposide—uterine cancer	0.000614	0.000845	CcSEcCtD
Anagrelide—Nausea—Dactinomycin—uterine cancer	0.000611	0.000842	CcSEcCtD
Anagrelide—Pneumonia—Doxorubicin—uterine cancer	0.000609	0.000839	CcSEcCtD
Anagrelide—Gastrointestinal pain—Etoposide—uterine cancer	0.000609	0.000839	CcSEcCtD
Anagrelide—Renal failure—Doxorubicin—uterine cancer	0.000595	0.00082	CcSEcCtD
Anagrelide—Urticaria—Etoposide—uterine cancer	0.000592	0.000815	CcSEcCtD
Anagrelide—Haemoglobin—Epirubicin—uterine cancer	0.000591	0.000813	CcSEcCtD
Anagrelide—Rhinitis—Epirubicin—uterine cancer	0.000589	0.000811	CcSEcCtD
Anagrelide—Body temperature increased—Etoposide—uterine cancer	0.000589	0.000811	CcSEcCtD
Anagrelide—Abdominal pain—Etoposide—uterine cancer	0.000589	0.000811	CcSEcCtD
Anagrelide—Conjunctivitis—Doxorubicin—uterine cancer	0.000589	0.000811	CcSEcCtD
Anagrelide—Urinary tract infection—Doxorubicin—uterine cancer	0.000589	0.000811	CcSEcCtD
Anagrelide—Hepatitis—Epirubicin—uterine cancer	0.000588	0.000809	CcSEcCtD
Anagrelide—Haemorrhage—Epirubicin—uterine cancer	0.000588	0.000809	CcSEcCtD
Anagrelide—Hypoaesthesia—Epirubicin—uterine cancer	0.000585	0.000805	CcSEcCtD
Anagrelide—Pharyngitis—Epirubicin—uterine cancer	0.000583	0.000803	CcSEcCtD
Anagrelide—Sweating—Doxorubicin—uterine cancer	0.000581	0.0008	CcSEcCtD
Anagrelide—Urinary tract disorder—Epirubicin—uterine cancer	0.00058	0.000799	CcSEcCtD
Anagrelide—Oedema peripheral—Epirubicin—uterine cancer	0.000579	0.000797	CcSEcCtD
Anagrelide—Haematuria—Doxorubicin—uterine cancer	0.000578	0.000795	CcSEcCtD
Anagrelide—Connective tissue disorder—Epirubicin—uterine cancer	0.000578	0.000795	CcSEcCtD
Anagrelide—Urethral disorder—Epirubicin—uterine cancer	0.000576	0.000793	CcSEcCtD
Anagrelide—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000573	0.000789	CcSEcCtD
Anagrelide—Epistaxis—Doxorubicin—uterine cancer	0.000571	0.000787	CcSEcCtD
Anagrelide—Sinusitis—Doxorubicin—uterine cancer	0.000568	0.000783	CcSEcCtD
Anagrelide—Visual impairment—Epirubicin—uterine cancer	0.000566	0.00078	CcSEcCtD
Anagrelide—Eye disorder—Epirubicin—uterine cancer	0.000549	0.000756	CcSEcCtD
Anagrelide—Tinnitus—Epirubicin—uterine cancer	0.000548	0.000755	CcSEcCtD
Anagrelide—Haemoglobin—Doxorubicin—uterine cancer	0.000547	0.000753	CcSEcCtD
Anagrelide—Cardiac disorder—Epirubicin—uterine cancer	0.000545	0.000751	CcSEcCtD
Anagrelide—Rhinitis—Doxorubicin—uterine cancer	0.000545	0.000751	CcSEcCtD
Anagrelide—Hepatitis—Doxorubicin—uterine cancer	0.000544	0.000749	CcSEcCtD
Anagrelide—Haemorrhage—Doxorubicin—uterine cancer	0.000544	0.000749	CcSEcCtD
Anagrelide—Hypoaesthesia—Doxorubicin—uterine cancer	0.000541	0.000745	CcSEcCtD
Anagrelide—Pharyngitis—Doxorubicin—uterine cancer	0.00054	0.000743	CcSEcCtD
Anagrelide—Urinary tract disorder—Doxorubicin—uterine cancer	0.000537	0.000739	CcSEcCtD
Anagrelide—Oedema peripheral—Doxorubicin—uterine cancer	0.000536	0.000738	CcSEcCtD
Anagrelide—Asthenia—Etoposide—uterine cancer	0.000534	0.000736	CcSEcCtD
Anagrelide—Connective tissue disorder—Doxorubicin—uterine cancer	0.000534	0.000736	CcSEcCtD
Anagrelide—Urethral disorder—Doxorubicin—uterine cancer	0.000533	0.000734	CcSEcCtD
Anagrelide—Mediastinal disorder—Epirubicin—uterine cancer	0.00053	0.000729	CcSEcCtD
Anagrelide—Chills—Epirubicin—uterine cancer	0.000527	0.000726	CcSEcCtD
Anagrelide—Pruritus—Etoposide—uterine cancer	0.000527	0.000726	CcSEcCtD
Anagrelide—Arrhythmia—Epirubicin—uterine cancer	0.000525	0.000723	CcSEcCtD
Anagrelide—Visual impairment—Doxorubicin—uterine cancer	0.000524	0.000722	CcSEcCtD
Anagrelide—Alopecia—Epirubicin—uterine cancer	0.000519	0.000715	CcSEcCtD
Anagrelide—Malnutrition—Epirubicin—uterine cancer	0.000512	0.000704	CcSEcCtD
Anagrelide—Diarrhoea—Etoposide—uterine cancer	0.00051	0.000702	CcSEcCtD
Anagrelide—Eye disorder—Doxorubicin—uterine cancer	0.000508	0.0007	CcSEcCtD
Anagrelide—Tinnitus—Doxorubicin—uterine cancer	0.000507	0.000698	CcSEcCtD
Anagrelide—Cardiac disorder—Doxorubicin—uterine cancer	0.000505	0.000695	CcSEcCtD
Anagrelide—Flatulence—Epirubicin—uterine cancer	0.000504	0.000694	CcSEcCtD
Anagrelide—Tension—Epirubicin—uterine cancer	0.000502	0.000691	CcSEcCtD
Anagrelide—Nervousness—Epirubicin—uterine cancer	0.000497	0.000684	CcSEcCtD
Anagrelide—Back pain—Epirubicin—uterine cancer	0.000495	0.000681	CcSEcCtD
Anagrelide—Dizziness—Etoposide—uterine cancer	0.000493	0.000678	CcSEcCtD
Anagrelide—Muscle spasms—Epirubicin—uterine cancer	0.000492	0.000677	CcSEcCtD
Anagrelide—Mediastinal disorder—Doxorubicin—uterine cancer	0.00049	0.000675	CcSEcCtD
Anagrelide—Chills—Doxorubicin—uterine cancer	0.000488	0.000672	CcSEcCtD
Anagrelide—Arrhythmia—Doxorubicin—uterine cancer	0.000486	0.000669	CcSEcCtD
Anagrelide—Vision blurred—Epirubicin—uterine cancer	0.000482	0.000664	CcSEcCtD
Anagrelide—Alopecia—Doxorubicin—uterine cancer	0.000481	0.000662	CcSEcCtD
Anagrelide—Ill-defined disorder—Epirubicin—uterine cancer	0.000475	0.000654	CcSEcCtD
Anagrelide—Vomiting—Etoposide—uterine cancer	0.000474	0.000652	CcSEcCtD
Anagrelide—Malnutrition—Doxorubicin—uterine cancer	0.000473	0.000652	CcSEcCtD
Anagrelide—Anaemia—Epirubicin—uterine cancer	0.000473	0.000651	CcSEcCtD
Anagrelide—Rash—Etoposide—uterine cancer	0.00047	0.000647	CcSEcCtD
Anagrelide—Dermatitis—Etoposide—uterine cancer	0.000469	0.000646	CcSEcCtD
Anagrelide—Headache—Etoposide—uterine cancer	0.000467	0.000643	CcSEcCtD
Anagrelide—Flatulence—Doxorubicin—uterine cancer	0.000466	0.000642	CcSEcCtD
Anagrelide—Tension—Doxorubicin—uterine cancer	0.000465	0.00064	CcSEcCtD
Anagrelide—Malaise—Epirubicin—uterine cancer	0.000461	0.000635	CcSEcCtD
Anagrelide—Nervousness—Doxorubicin—uterine cancer	0.00046	0.000633	CcSEcCtD
Anagrelide—Syncope—Epirubicin—uterine cancer	0.000459	0.000632	CcSEcCtD
Anagrelide—Back pain—Doxorubicin—uterine cancer	0.000458	0.000631	CcSEcCtD
Anagrelide—Muscle spasms—Doxorubicin—uterine cancer	0.000455	0.000627	CcSEcCtD
Anagrelide—Palpitations—Epirubicin—uterine cancer	0.000452	0.000623	CcSEcCtD
Anagrelide—Loss of consciousness—Epirubicin—uterine cancer	0.00045	0.000619	CcSEcCtD
Anagrelide—Cough—Epirubicin—uterine cancer	0.000446	0.000615	CcSEcCtD
Anagrelide—Vision blurred—Doxorubicin—uterine cancer	0.000446	0.000614	CcSEcCtD
Anagrelide—Convulsion—Epirubicin—uterine cancer	0.000443	0.00061	CcSEcCtD
Anagrelide—Nausea—Etoposide—uterine cancer	0.000442	0.000609	CcSEcCtD
Anagrelide—Hypertension—Epirubicin—uterine cancer	0.000442	0.000608	CcSEcCtD
Anagrelide—Ill-defined disorder—Doxorubicin—uterine cancer	0.000439	0.000605	CcSEcCtD
Anagrelide—Anaemia—Doxorubicin—uterine cancer	0.000438	0.000602	CcSEcCtD
Anagrelide—Arthralgia—Epirubicin—uterine cancer	0.000436	0.0006	CcSEcCtD
Anagrelide—Chest pain—Epirubicin—uterine cancer	0.000436	0.0006	CcSEcCtD
Anagrelide—Myalgia—Epirubicin—uterine cancer	0.000436	0.0006	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000433	0.000596	CcSEcCtD
Anagrelide—Discomfort—Epirubicin—uterine cancer	0.00043	0.000593	CcSEcCtD
Anagrelide—Malaise—Doxorubicin—uterine cancer	0.000427	0.000588	CcSEcCtD
Anagrelide—Dry mouth—Epirubicin—uterine cancer	0.000426	0.000587	CcSEcCtD
Anagrelide—Syncope—Doxorubicin—uterine cancer	0.000425	0.000585	CcSEcCtD
Anagrelide—Confusional state—Epirubicin—uterine cancer	0.000421	0.00058	CcSEcCtD
Anagrelide—Palpitations—Doxorubicin—uterine cancer	0.000418	0.000576	CcSEcCtD
Anagrelide—Oedema—Epirubicin—uterine cancer	0.000418	0.000575	CcSEcCtD
Anagrelide—Loss of consciousness—Doxorubicin—uterine cancer	0.000416	0.000573	CcSEcCtD
Anagrelide—Infection—Epirubicin—uterine cancer	0.000415	0.000571	CcSEcCtD
Anagrelide—Cough—Doxorubicin—uterine cancer	0.000413	0.000569	CcSEcCtD
Anagrelide—Shock—Epirubicin—uterine cancer	0.000411	0.000566	CcSEcCtD
Anagrelide—Convulsion—Doxorubicin—uterine cancer	0.00041	0.000565	CcSEcCtD
Anagrelide—Nervous system disorder—Epirubicin—uterine cancer	0.000409	0.000564	CcSEcCtD
Anagrelide—Thrombocytopenia—Epirubicin—uterine cancer	0.000409	0.000563	CcSEcCtD
Anagrelide—Hypertension—Doxorubicin—uterine cancer	0.000409	0.000563	CcSEcCtD
Anagrelide—Tachycardia—Epirubicin—uterine cancer	0.000408	0.000561	CcSEcCtD
Anagrelide—Skin disorder—Epirubicin—uterine cancer	0.000406	0.000558	CcSEcCtD
Anagrelide—Hyperhidrosis—Epirubicin—uterine cancer	0.000404	0.000556	CcSEcCtD
Anagrelide—Arthralgia—Doxorubicin—uterine cancer	0.000403	0.000555	CcSEcCtD
Anagrelide—Myalgia—Doxorubicin—uterine cancer	0.000403	0.000555	CcSEcCtD
Anagrelide—Chest pain—Doxorubicin—uterine cancer	0.000403	0.000555	CcSEcCtD
Anagrelide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.0004	0.000551	CcSEcCtD
Anagrelide—Discomfort—Doxorubicin—uterine cancer	0.000398	0.000548	CcSEcCtD
Anagrelide—Anorexia—Epirubicin—uterine cancer	0.000398	0.000548	CcSEcCtD
Anagrelide—Dry mouth—Doxorubicin—uterine cancer	0.000394	0.000543	CcSEcCtD
Anagrelide—Hypotension—Epirubicin—uterine cancer	0.00039	0.000537	CcSEcCtD
Anagrelide—Confusional state—Doxorubicin—uterine cancer	0.00039	0.000536	CcSEcCtD
Anagrelide—Oedema—Doxorubicin—uterine cancer	0.000386	0.000532	CcSEcCtD
Anagrelide—Infection—Doxorubicin—uterine cancer	0.000384	0.000529	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00038	0.000524	CcSEcCtD
Anagrelide—Shock—Doxorubicin—uterine cancer	0.00038	0.000523	CcSEcCtD
Anagrelide—Nervous system disorder—Doxorubicin—uterine cancer	0.000379	0.000522	CcSEcCtD
Anagrelide—Thrombocytopenia—Doxorubicin—uterine cancer	0.000378	0.000521	CcSEcCtD
Anagrelide—Insomnia—Epirubicin—uterine cancer	0.000378	0.00052	CcSEcCtD
Anagrelide—Tachycardia—Doxorubicin—uterine cancer	0.000377	0.000519	CcSEcCtD
Anagrelide—Skin disorder—Doxorubicin—uterine cancer	0.000375	0.000517	CcSEcCtD
Anagrelide—Paraesthesia—Epirubicin—uterine cancer	0.000375	0.000516	CcSEcCtD
Anagrelide—Hyperhidrosis—Doxorubicin—uterine cancer	0.000374	0.000514	CcSEcCtD
Anagrelide—Dyspnoea—Epirubicin—uterine cancer	0.000372	0.000513	CcSEcCtD
Anagrelide—Somnolence—Epirubicin—uterine cancer	0.000371	0.000511	CcSEcCtD
Anagrelide—Anorexia—Doxorubicin—uterine cancer	0.000368	0.000507	CcSEcCtD
Anagrelide—Dyspepsia—Epirubicin—uterine cancer	0.000368	0.000506	CcSEcCtD
Anagrelide—Decreased appetite—Epirubicin—uterine cancer	0.000363	0.0005	CcSEcCtD
Anagrelide—Hypotension—Doxorubicin—uterine cancer	0.000361	0.000497	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00036	0.000496	CcSEcCtD
Anagrelide—Fatigue—Epirubicin—uterine cancer	0.00036	0.000496	CcSEcCtD
Anagrelide—Pain—Epirubicin—uterine cancer	0.000357	0.000492	CcSEcCtD
Anagrelide—Constipation—Epirubicin—uterine cancer	0.000357	0.000492	CcSEcCtD
Anagrelide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000352	0.000485	CcSEcCtD
Anagrelide—Insomnia—Doxorubicin—uterine cancer	0.000349	0.000481	CcSEcCtD
Anagrelide—Paraesthesia—Doxorubicin—uterine cancer	0.000347	0.000478	CcSEcCtD
Anagrelide—Dyspnoea—Doxorubicin—uterine cancer	0.000344	0.000474	CcSEcCtD
Anagrelide—Feeling abnormal—Epirubicin—uterine cancer	0.000344	0.000474	CcSEcCtD
Anagrelide—Somnolence—Doxorubicin—uterine cancer	0.000343	0.000473	CcSEcCtD
Anagrelide—Gastrointestinal pain—Epirubicin—uterine cancer	0.000341	0.00047	CcSEcCtD
Anagrelide—Dyspepsia—Doxorubicin—uterine cancer	0.00034	0.000468	CcSEcCtD
Anagrelide—Decreased appetite—Doxorubicin—uterine cancer	0.000336	0.000462	CcSEcCtD
Anagrelide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000334	0.000459	CcSEcCtD
Anagrelide—Fatigue—Doxorubicin—uterine cancer	0.000333	0.000459	CcSEcCtD
Anagrelide—Urticaria—Epirubicin—uterine cancer	0.000332	0.000457	CcSEcCtD
Anagrelide—Pain—Doxorubicin—uterine cancer	0.00033	0.000455	CcSEcCtD
Anagrelide—Constipation—Doxorubicin—uterine cancer	0.00033	0.000455	CcSEcCtD
Anagrelide—Abdominal pain—Epirubicin—uterine cancer	0.00033	0.000455	CcSEcCtD
Anagrelide—Body temperature increased—Epirubicin—uterine cancer	0.00033	0.000455	CcSEcCtD
Anagrelide—Feeling abnormal—Doxorubicin—uterine cancer	0.000318	0.000438	CcSEcCtD
Anagrelide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000316	0.000435	CcSEcCtD
Anagrelide—Urticaria—Doxorubicin—uterine cancer	0.000307	0.000423	CcSEcCtD
Anagrelide—Body temperature increased—Doxorubicin—uterine cancer	0.000305	0.000421	CcSEcCtD
Anagrelide—Abdominal pain—Doxorubicin—uterine cancer	0.000305	0.000421	CcSEcCtD
Anagrelide—Asthenia—Epirubicin—uterine cancer	0.0003	0.000413	CcSEcCtD
Anagrelide—Pruritus—Epirubicin—uterine cancer	0.000295	0.000407	CcSEcCtD
Anagrelide—Diarrhoea—Epirubicin—uterine cancer	0.000286	0.000393	CcSEcCtD
Anagrelide—Asthenia—Doxorubicin—uterine cancer	0.000277	0.000382	CcSEcCtD
Anagrelide—Dizziness—Epirubicin—uterine cancer	0.000276	0.00038	CcSEcCtD
Anagrelide—Pruritus—Doxorubicin—uterine cancer	0.000273	0.000376	CcSEcCtD
Anagrelide—Vomiting—Epirubicin—uterine cancer	0.000265	0.000366	CcSEcCtD
Anagrelide—Diarrhoea—Doxorubicin—uterine cancer	0.000264	0.000364	CcSEcCtD
Anagrelide—Rash—Epirubicin—uterine cancer	0.000263	0.000363	CcSEcCtD
Anagrelide—Dermatitis—Epirubicin—uterine cancer	0.000263	0.000362	CcSEcCtD
Anagrelide—Headache—Epirubicin—uterine cancer	0.000262	0.00036	CcSEcCtD
Anagrelide—Dizziness—Doxorubicin—uterine cancer	0.000255	0.000352	CcSEcCtD
Anagrelide—Nausea—Epirubicin—uterine cancer	0.000248	0.000342	CcSEcCtD
Anagrelide—Vomiting—Doxorubicin—uterine cancer	0.000246	0.000338	CcSEcCtD
Anagrelide—Rash—Doxorubicin—uterine cancer	0.000244	0.000335	CcSEcCtD
Anagrelide—Dermatitis—Doxorubicin—uterine cancer	0.000243	0.000335	CcSEcCtD
Anagrelide—Headache—Doxorubicin—uterine cancer	0.000242	0.000333	CcSEcCtD
Anagrelide—Nausea—Doxorubicin—uterine cancer	0.000229	0.000316	CcSEcCtD
